Aarti Pharmalabs Limited — Updates, 30-06-2026: Press Release
30-06-2026 | 05:56 pm
30-06-2026 | 05:56 pm
Aarti Pharmalabs inaugurated a new manufacturing block at Tarapur, adding 3600 TPA to Xanthine derivatives capacity, now totaling 9600 TPA. This positions them among the top 3 global manufacturers. Trial production has begun, with full utilization expected in coming quarters.
No comments yet. Be the first to comment!
